SAN DIEGO–(BUSINESS WIRE)–Quidel Company (NASDAQ: QDEL), a supplier of fast diagnostic testing options, cellular-based virology assays and molecular diagnostic techniques, will report third fiscal quarter 2020 monetary outcomes after market shut on Thursday, October 29, 2020.
Following the discharge of outcomes, Douglas Bryant, president and chief government officer, and Randy Steward, chief monetary officer, will host an funding group convention name starting at 5:00 p.m. Jap Time (2:00 p.m. Pacific Time) to debate the outcomes and reply questions. Through the convention name, the corporate can even talk about enterprise and monetary developments and developments. The corporate’s statements could include or represent materials data that has not been beforehand disclosed.
Buyers could both be a part of the dwell name by phone, or through webcast:
- To take part within the dwell name by phone from the U.S., dial 833-968-2118, or from outdoors the U.S., dial 778-560-2849, and both request the “Quidel Q3 2020 Earnings Name” when prompted by the convention name operator, or dial convention ID 688-9542.
- To affix the dwell webcast, members could click on the next hyperlink instantly: https://occasion.on24.com/wcc/r/2625296/E75E2243C47118925001E5956E2A2D04, or entry the occasion through the Investor Relations part of the Quidel web site (http://ir.quidel.com).
The web site replay will likely be accessible for 1 12 months. The phone replay will likely be accessible for 14 days starting at eight:00 p.m. Jap Time (5:00 p.m. Pacific Time) on October 29th, 2020 by dialing 800-585-8367 from the U.S., or by dialing 416-621-4642 for worldwide callers, and coming into cross code 688-9542.
About Quidel Company
Quidel Company serves to reinforce the well being and well-being of individuals across the globe by the event of diagnostic options that may result in improved affected person outcomes and supply financial advantages to the healthcare system. Marketed underneath the Sofia®, QuickVue®, D3® Direct Detection, Thyretain®, Triage® and InflammaDry® main model names, in addition to underneath the Solana®, AmpliVue® and Lyra® molecular diagnostic manufacturers, Quidel’s merchandise support within the detection and analysis of many essential illnesses and circumstances, together with, amongst others, COVID-19, influenza, respiratory syncytial virus, Strep A, lyme, herpes, being pregnant, thyroid illness and fecal occult blood. Quidel’s Triage® system of checks contains a complete check menu that gives fast, cost-effective remedy choices on the point-of-care (POC), providing a various immunoassay menu in quite a lot of checks to offer diagnostic solutions for quantitative BNP, CK-MB, d-dimer, myoglobin, troponin I and qualitative TOX Drug Display screen. Quidel’s analysis and improvement engine can be creating a continuum of diagnostic options from superior immunoassay to molecular diagnostic checks to additional enhance the standard of healthcare in physicians’ places of work and hospital and reference laboratories. For extra details about Quidel’s complete product portfolio, and to discover thrilling employment alternatives, go to quidel.com.